Literature DB >> 20699421

Proteomic analysis of electronegative low-density lipoprotein.

Cristina Bancells1, Francesc Canals, Sònia Benítez, Nuria Colomé, Josep Julve, Jordi Ordóñez-Llanos, José Luis Sánchez-Quesada.   

Abstract

Low density lipoprotein is a heterogeneous group of lipoproteins that differs in lipid and protein composition. One copy of apolipoprotein (apo)B accounts for over 95% of the LDL protein, but the presence of minor proteins could disturb its biological behavior. Our aim was to study the content of minor proteins in LDL subfractions separated by anion exchange chromatography. Electropositive LDL [LDL(+)] is the native form, whereas electronegative LDL [LDL⁻] is a minor atherogenic fraction present in blood. LC-ESI MS/MS analysis of both LDL fractions identified up to 28 different proteins. Of these, 13 proteins, including apoB, were detected in all the analyzed samples. LDL⁻ showed a higher content of most minor proteins. Statistical analysis of proteomic data indicated that the content of apoE, apoA-I, apoC-III, apoA-II, apoD, apoF, and apoJ was higher in LDL⁻ than in LDL(+). Immunoturbidimetry, ELISA, or Western blot analysis confirmed these differences. ApoJ and apoF presented the highest difference between LDL(+) and LDL⁻ (>15-fold). In summary, the increased content of several apolipoproteins, and specifically of apoF and apoJ, could be related to the physicochemical characteristics of LDL⁻, such as apoB misfolding, aggregation, and abnormal lipid composition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20699421      PMCID: PMC2975723          DOI: 10.1194/jlr.M009258

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  36 in total

Review 1.  Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families.

Authors:  P Alaupovic
Journal:  Prog Lipid Res       Date:  1991       Impact factor: 16.195

Review 2.  Lipoprotein heterogeneity and its effect on apolipoprotein assays.

Authors:  J C Fruchart
Journal:  Scand J Clin Lab Invest Suppl       Date:  1990

3.  Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(-).

Authors:  T Parasassi; G Bittolo-Bon; R Brunelli; G Cazzolato; E K Krasnowska; G Mei; A Sevanian; F Ursini
Journal:  Free Radic Biol Med       Date:  2001-07-01       Impact factor: 7.376

4.  ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.

Authors:  J C Escolà-Gil; J Julve; A Marzal-Casacuberta ; J Ordóñez-Llanos; F González-Sastre; F Blanco-Vaca
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

5.  Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells.

Authors:  C De Castellarnau; J L Sánchez-Quesada; S Benítez; R Rosa; L Caveda; L Vila; J Ordóñez-Llanos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

6.  Electronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cells.

Authors:  José Luis Sánchez-Quesada; Mercedes Camacho; Rosa Antón; Sonia Benítez; Lluis Vila; Jordi Ordóñez-Llanos
Journal:  Atherosclerosis       Date:  2003-02       Impact factor: 5.162

7.  Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.

Authors:  P Alaupovic; C Knight-Gibson; C S Wang; D Downs; E Koren; H B Brewer; R E Gregg
Journal:  J Lipid Res       Date:  1991-01       Impact factor: 5.922

8.  Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.

Authors:  Sonia Benítez; Jordi Ordóñez-Llanos; Miquel Franco; Carmen Marín; Elier Paz; José López-Miranda; Carles Otal; Francisco Pérez-Jiménez; José Luis Sánchez-Quesada
Journal:  Am J Cardiol       Date:  2004-02-15       Impact factor: 2.778

9.  Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction.

Authors:  Sonia Benítez; José Luis Sánchez-Quesada; Vicent Ribas; Oscar Jorba; Francisco Blanco-Vaca; Francesc González-Sastre; Jordi Ordóñez-Llanos
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

10.  Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes.

Authors:  R E Morton; D J Greene
Journal:  J Lipid Res       Date:  1994-05       Impact factor: 5.922

View more
  21 in total

1.  A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins.

Authors:  Scott M Gordon; Hailong Li; Xiaoting Zhu; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2015-04-27       Impact factor: 4.466

2.  A Comparison of Methods To Enhance Protein Detection of Lipoproteins by Mass Spectrometry.

Authors:  Anna Heink; W Sean Davidson; Debi K Swertfeger; L Jason Lu; Amy S Shah
Journal:  J Proteome Res       Date:  2015-06-12       Impact factor: 4.466

3.  Thermal stability of human plasma electronegative low-density lipoprotein: A paradoxical behavior of low-density lipoprotein aggregation.

Authors:  Anna Rull; Shobini Jayaraman; Donald L Gantz; Andrea Rivas-Urbina; Montserrat Pérez-Cuellar; Jordi Ordóñez-Llanos; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta       Date:  2016-05-24

4.  Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma.

Authors:  Debi K Swertfeger; Hailong Li; Sandra Rebholz; Xiaoting Zhu; Amy S Shah; W Sean Davidson; Long J Lu
Journal:  Mol Cell Proteomics       Date:  2017-02-21       Impact factor: 5.911

5.  Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL.

Authors:  Naoko Sawada; Takashi Obama; Shinji Koba; Takashi Takaki; Sanju Iwamoto; Toshihiro Aiuchi; Rina Kato; Masaki Kikuchi; Yuji Hamazaki; Hiroyuki Itabe
Journal:  J Lipid Res       Date:  2020-04-14       Impact factor: 5.922

6.  Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis.

Authors:  William R Lagor; David W Fields; Robert C Bauer; Alison Crawford; Michael C Abt; David Artis; E John Wherry; Daniel J Rader
Journal:  Atherosclerosis       Date:  2014-01-10       Impact factor: 5.162

7.  Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein.

Authors:  Liang-Yin Ke; David A Engler; Jonathan Lu; Risë K Matsunami; Hua-Chen Chan; Guei-Jane Wang; Chao-Yuh Yang; Jan-Gowth Chang; Chu-Huang Chen
Journal:  Pure Appl Chem       Date:  2011       Impact factor: 2.453

Review 8.  The underlying chemistry of electronegative LDL's atherogenicity.

Authors:  Liang-Yin Ke; Nicole Stancel; Henry Bair; Chu-Huang Chen
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

9.  The Induction of Cytokine Release in Monocytes by Electronegative Low-Density Lipoprotein (LDL) Is Related to Its Higher Ceramide Content than Native LDL.

Authors:  Montserrat Estruch; Jose Luis Sanchez-Quesada; Lorea Beloki; Jordi Ordoñez-Llanos; Sonia Benitez
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

Review 10.  Electronegative LDL: a circulating modified LDL with a role in inflammation.

Authors:  Montserrat Estruch; José Luis Sánchez-Quesada; Jordi Ordóñez Llanos; Sònia Benítez
Journal:  Mediators Inflamm       Date:  2013-08-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.